MoneyWorks4Me

Mercury Laboratories informs about disclosure

21 Nov 2020 Evaluate
In terms of Regulation 23(9) of the Securities and Exchange Board Of India (Listing Obligations and Disclosure Requirements) Regulations, Mercury Laboratories has informed that it has enclosed disclosure of Related Party Transaction on consolidated basis, in the format specified in the accounting standards for the half year ended September 30, 2020.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1244.50
Cipla 1384.85
Lupin 2076.00
Zydus Lifesciences 1214.25
View more..